by Truveta Research | Oct 31, 2022 | Research, Research Insights
On February 17, 2022, Abbott voluntarily recalled powdered formula made in a Michigan facility due to complaints of Cronobacter sakazakii and Salmonella Newport contamination [1]. Datasembly reported that baby formula was out-of-stock at 31% of stores in April 2022...
by Truveta staff | Oct 11, 2022 | Culture
Truveta is a place for researchers, and this team works with the vast volume of data in Truveta Studio. They ask and answer critical clinical research questions, surface insights, conduct research studies, and partner with health system members and life science...
by Truveta staff | Oct 5, 2022 | News
Let’s catch up We just hosted a LinkedIn Live, “Monitoring Medical Device Outcomes & Health Disparities,” with three Truveta leaders — our CEO, Terry Myerson; Chief Medical Officer, Dr. Ryan Ahern, MD, MPH; and VP of Communications, Lish Mark. They...
by Truveta Research | Oct 4, 2022 | Research, Research Insights
Peripheral Artery Disease (PAD) is a common disease that causes the arteries in the extremities to narrow. Recently, as part of PAD Awareness Month, we investigated disparities in the frequency of common procedures used to treat PAD, known as endovascular (or...
by Terry Myerson, CEO | Sep 27, 2022 | News
One of the biggest challenges the healthcare industry faces today is getting fast answers to pressing medical questions on any disease, drug, or device. To address this critical need, Truveta is a collective of 24 health systems who came together with a...
